Samantha Schimmel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samantha Schimmel has a total of 292 co-authors. Here are the top co-authors by number of shared publications:
- Kunal Vakharia
Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, Florida, USA
8 shared publications - Atakan Orscelik
Department of Neurological Surgery and Radiology, Mayo Clinic, Rochester, United States
6 shared publications - David Joseph Altschul
Department of Neurological Surgery and Montefiore-Einstein Cerebrovascular Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
6 shared publications - Dhairya A. Lakhani
Department of Neuroradiology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV 26506, USA
6 shared publications - Dominik F. Vollherbst
Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany
6 shared publications - Joseph Anthony Carnevale
Department of Neurological Surgery, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, United States
6 shared publications
Latest Publications
- 23 October 2026
- Published by Wolters Kluwer Health in Neurosurgery
Machine Learning Prediction of Treatment Failure After Middle Meningeal Artery Embolization for Subdural Hematoma
BACKGROUND AND OBJECTIVES: Middle meningeal artery embolization (MMAE) is effective for chronic subdural hematoma (SDH), but failure rates vary and risk prediction tools are lacking. This study developed and validated a machine learning (ML) model to predict MMAE treatment failure for SDH. METHODS: We conducted an international, multi-institutional retrospective cohort study of patients who underwent MMAE for SDH between 2019 and 2025. The cohort was split into training and test sets, stratified by treatment failure, with all hematomas from each patient assigned to a single cohort to prevent data leakage. Multiple ML algorithms were evaluated using 5-fold cross-validation, with gradient boosting selected as the final model. The primary outcome was treatment failure, defined as rescue surgical evacuation or persistent/recurrent SDH requiring retreatment. Model performance was assessed using area under the curve-receiver operating characteristic. Patients were stratified into low-risk (15%) groups using a priori clinically defined thresholds. RESULTS: Among 692 treated hematomas in the test cohort, 64 (9.2%) experienced treatment failure. The gradient boosting model achieved an area under the curve-receiver operating characteristic of 0.856 (95% CI, 0.803-0.902) before calibration and 0.832 (95% CI, 0.766-0.889) after isotonic calibration, with excellent calibration (Brier score, 0.053). The most important predictors were age-platelet interaction, platelet-hemoglobin ratio, platelet count, SDH thickness, and age. Observed treatment failure was 1.6% (95% CI, 0.4%-5.7%) in the low-risk group (n = 124; 17.9%), 6.0% (95% CI, 4.3%-8.4%) in the medium-risk group (n = 516; 74.6%), and 59.6% (95% CI, 46.1%-71.8%) in the high-risk group (n = 52; 7.5%) ( P < .001 for trend), a 37.2-fold difference between high- and low-risk groups. CONCLUSION: This ML model stratified MMAE patients into risk groups with a 37.2-fold difference in treatment failure. High-risk patients had 59.6% failure, whereas low-risk patients had 1.6% failure. Risk stratification may improve patient selection and monitoring.
- 23 October 2026
- Published by Wolters Kluwer Health in Neurosurgery
Machine Learning Prediction of Treatment Failure After Middle Meningeal Artery Embolization for Subdural Hematoma
BACKGROUND AND OBJECTIVES: Middle meningeal artery embolization (MMAE) is effective for chronic subdural hematoma (SDH), but failure rates vary and risk prediction tools are lacking. This study developed and validated a machine learning (ML) model to predict MMAE treatment failure for SDH. METHODS: We conducted an international, multi-institutional retrospective cohort study of patients who underwent MMAE for SDH between 2019 and 2025. The cohort was split into training and test sets, stratified by treatment failure, with all hematomas from each patient assigned to a single cohort to prevent data leakage. Multiple ML algorithms were evaluated using 5-fold cross-validation, with gradient boosting selected as the final model. The primary outcome was treatment failure, defined as rescue surgical evacuation or persistent/recurrent SDH requiring retreatment. Model performance was assessed using area under the curve-receiver operating characteristic. Patients were stratified into low-risk (15%) groups using a priori clinically defined thresholds. RESULTS: Among 692 treated hematomas in the test cohort, 64 (9.2%) experienced treatment failure. The gradient boosting model achieved an area under the curve-receiver operating characteristic of 0.856 (95% CI, 0.803-0.902) before calibration and 0.832 (95% CI, 0.766-0.889) after isotonic calibration, with excellent calibration (Brier score, 0.053). The most important predictors were age-platelet interaction, platelet-hemoglobin ratio, platelet count, SDH thickness, and age. Observed treatment failure was 1.6% (95% CI, 0.4%-5.7%) in the low-risk group (n = 124; 17.9%), 6.0% (95% CI, 4.3%-8.4%) in the medium-risk group (n = 516; 74.6%), and 59.6% (95% CI, 46.1%-71.8%) in the high-risk group (n = 52; 7.5%) ( P < .001 for trend), a 37.2-fold difference between high- and low-risk groups. CONCLUSION: This ML model stratified MMAE patients into risk groups with a 37.2-fold difference in treatment failure. High-risk patients had 59.6% failure, whereas low-risk patients had 1.6% failure. Risk stratification may improve patient selection and monitoring.
- 20 October 2026
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
Admission functional status and selection for surgical evacuation as an adjunct to middle meningeal artery embolisation for chronic subdural haematoma: the MESH registry
Background Middle meningeal artery embolisation (MMAE) reduces treatment failure in chronic subdural haematoma (cSDH), but it remains unclear whether to add surgery and which patients benefit. We examined whether adding surgery improves functional recovery, accounting for admission status. Methods We conducted a multicentre cohort study of 2075 patients with cSDH treated with MMAE across 33 sites. The primary outcome was excellent functional recovery (modified Rankin Scale (mRS) 0–1) at the last recorded assessment, the timepoint with highest ascertainment (n=1854); a pre-specified 90-day analysis tested whether the timepoint determined the result. The effect modifier was admission functional status (mRS ≥2 vs 0–1), with doubly robust adjustment for measured baseline differences. Results Among 797 patients impaired at admission, excellent recovery occurred in 111/364 (30%) with surgery plus MMAE versus 101/433 (23%) with MMAE alone (adjusted difference 8.2 percentage points; 95% CI 0.8 to 15.5); among 1057 independent patients, it was 3.1 (−3.8 to 9.9). At 90 days, the impaired-group estimate was similar but less precise (7.5; −4.7 to 19.7; n=436), so the finding did not depend on the timepoint. The difference was largest with haematoma volume >80 mL (17.6; 6.6 to 28.6) and was absent for functional independence, freedom from recurrence or reoperation and survival. Surgical complications occurred in 9/195 (4.6%) impaired patients undergoing evacuation. Conclusions Adding surgery was associated with greater excellent functional recovery among admission-impaired but not already independent patients, consistently at 90 days and confined to the excellent-recovery threshold. Randomised validation stratified by admission function is warranted.
- 20 October 2026
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
Admission functional status and selection for surgical evacuation as an adjunct to middle meningeal artery embolisation for chronic subdural haematoma: the MESH registry
Background Middle meningeal artery embolisation (MMAE) reduces treatment failure in chronic subdural haematoma (cSDH), but it remains unclear whether to add surgery and which patients benefit. We examined whether adding surgery improves functional recovery, accounting for admission status. Methods We conducted a multicentre cohort study of 2075 patients with cSDH treated with MMAE across 33 sites. The primary outcome was excellent functional recovery (modified Rankin Scale (mRS) 0–1) at the last recorded assessment, the timepoint with highest ascertainment (n=1854); a pre-specified 90-day analysis tested whether the timepoint determined the result. The effect modifier was admission functional status (mRS ≥2 vs 0–1), with doubly robust adjustment for measured baseline differences. Results Among 797 patients impaired at admission, excellent recovery occurred in 111/364 (30%) with surgery plus MMAE versus 101/433 (23%) with MMAE alone (adjusted difference 8.2 percentage points; 95% CI 0.8 to 15.5); among 1057 independent patients, it was 3.1 (−3.8 to 9.9). At 90 days, the impaired-group estimate was similar but less precise (7.5; −4.7 to 19.7; n=436), so the finding did not depend on the timepoint. The difference was largest with haematoma volume >80 mL (17.6; 6.6 to 28.6) and was absent for functional independence, freedom from recurrence or reoperation and survival. Surgical complications occurred in 9/195 (4.6%) impaired patients undergoing evacuation. Conclusions Adding surgery was associated with greater excellent functional recovery among admission-impaired but not already independent patients, consistently at 90 days and confined to the excellent-recovery threshold. Randomised validation stratified by admission function is warranted.
- Open Access
- 15 October 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-14
Liquid Embolic Volume Does Not Predict Outcome After Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Purpose: Middle meningeal artery embolization (MMAE) is increasingly used for chronic subdural hematoma (CSDH), but the relationship between injected liquid-embolic volume and outcomes is unclear. We evaluated dose–outcome associations and searched for a minimum effective dose. Methods: This retrospective multicenter cohort included 313 patients treated with liquid embolic agents at 12 MESH Registry centers from 2016 to 2024. MMAE was performed alone in 172 patients (55.0%) and adjunctively with surgical evacuation in 141 (45.0%). Dose was assessed as total injected volume per patient and normalized to middle meningeal artery diameter, baseline hematoma thickness, and estimated hematoma volume. The primary outcome was a 180-day composite of retreatment, residual or recurrent hematoma > 10 mm, or death. Logistic regression with multiple imputation, restricted cubic splines, and sensitivity analyses evaluated associations and nonlinearity. Results: Median injected volume was 0.60 mL (interquartile range, 0.50–0.90). Center accounted for 44.5% of variation in log volume, whereas hematoma burden accounted for 0.3%. No dose metric was significantly associated with the primary outcome or 90-day recurrence/reoperation. For absolute volume, the odds ratio per interquartile-range increment was 0.80 (95% confidence interval, 0.56–1.16; p = 0.24). No reliable minimum effective dose was identified. Findings remained consistent across sensitivity analyses and treatment indications (interaction p = 0.30). Procedural complications occurred in 6.4% and were not dose-associated. Conclusion: Within the observed range, injected volume alone was not a consistent determinant of outcome and should not be a procedural target after a satisfactory angiographic endpoint. Future studies should evaluate embolic distribution, distal penetration, and vascular territory coverage.
- 15 October 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-14
Open AccessLiquid Embolic Volume Does Not Predict Outcome After Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Purpose: Middle meningeal artery embolization (MMAE) is increasingly used for chronic subdural hematoma (CSDH), but the relationship between injected liquid-embolic volume and outcomes is unclear. We evaluated dose–outcome associations and searched for a minimum effective dose. Methods: This retrospective multicenter cohort included 313 patients treated with liquid embolic agents at 12 MESH Registry centers from 2016 to 2024. MMAE was performed alone in 172 patients (55.0%) and adjunctively with surgical evacuation in 141 (45.0%). Dose was assessed as total injected volume per patient and normalized to middle meningeal artery diameter, baseline hematoma thickness, and estimated hematoma volume. The primary outcome was a 180-day composite of retreatment, residual or recurrent hematoma > 10 mm, or death. Logistic regression with multiple imputation, restricted cubic splines, and sensitivity analyses evaluated associations and nonlinearity. Results: Median injected volume was 0.60 mL (interquartile range, 0.50–0.90). Center accounted for 44.5% of variation in log volume, whereas hematoma burden accounted for 0.3%. No dose metric was significantly associated with the primary outcome or 90-day recurrence/reoperation. For absolute volume, the odds ratio per interquartile-range increment was 0.80 (95% confidence interval, 0.56–1.16; p = 0.24). No reliable minimum effective dose was identified. Findings remained consistent across sensitivity analyses and treatment indications (interaction p = 0.30). Procedural complications occurred in 6.4% and were not dose-associated. Conclusion: Within the observed range, injected volume alone was not a consistent determinant of outcome and should not be a procedural target after a satisfactory angiographic endpoint. Future studies should evaluate embolic distribution, distal penetration, and vascular territory coverage.
- Open Access
- 21 September 2026
- Published by Springer Nature in Neuroradiology
- p. 1-12
Multi-pedicle versus single-pedicle middle meningeal artery embolization for nonacute subdural hematoma
Introduction: Nonacute subdural hematomas (nSDH) are common yet serious extra-axial hemorrhages that result in significant morbidity and mortality. Middle meningeal artery (MMA) embolization (MMAE) is a recent endovascular treatment that involves occlusion of the MMA, inducing hemostasis in and around the hematoma. While many aspects of MMAE have been explored, there is currently limited data on the optimal extent of embolization. Objective: To determine whether single or multiple pedicle embolization of the MMA is superior in inducing hemostasis in nSDH. Methods: We compared single versus multi pedicle embolization by a retrospective multicenter analysis of nSDH patients who underwent MMAE between 2019 and 2024 at participating centers in the MESH (MMA Embolization for Subdural Hematoma) Registry. 679 patients who received a liquid embolic agent with branch-level embolization data were included. Results: While multi-pedicle embolization hastened nSDH thinning at 1 month (5.7 vs. 3.3 mm reduction; difference 2.4 mm, 95% CI 1.0–3.8; P = .002), by 3 months thickness reduction had converged between groups (8.2 vs. 8.4 mm; P = .91). Among 679 patients (456 multi-pedicle, 223 single-pedicle), favorable functional outcome (mRS 0–2) was more frequent with multi-pedicle embolization (53.5% vs. 43.0%; adjusted OR 1.81, 95% CI 1.26–2.60; P = .001), whereas recurrence, rescue surgery, and treatment failure did not differ. Conclusion: Future, multi-center randomized prospective trials are warranted to address confounding variables that limit this observational study. Follow-up beyond 3 months was limited, so durability is unknown.
- 21 September 2026
- Published by Springer Nature in Neuroradiology
- p. 1-12
Open AccessMulti-pedicle versus single-pedicle middle meningeal artery embolization for nonacute subdural hematoma
Introduction: Nonacute subdural hematomas (nSDH) are common yet serious extra-axial hemorrhages that result in significant morbidity and mortality. Middle meningeal artery (MMA) embolization (MMAE) is a recent endovascular treatment that involves occlusion of the MMA, inducing hemostasis in and around the hematoma. While many aspects of MMAE have been explored, there is currently limited data on the optimal extent of embolization. Objective: To determine whether single or multiple pedicle embolization of the MMA is superior in inducing hemostasis in nSDH. Methods: We compared single versus multi pedicle embolization by a retrospective multicenter analysis of nSDH patients who underwent MMAE between 2019 and 2024 at participating centers in the MESH (MMA Embolization for Subdural Hematoma) Registry. 679 patients who received a liquid embolic agent with branch-level embolization data were included. Results: While multi-pedicle embolization hastened nSDH thinning at 1 month (5.7 vs. 3.3 mm reduction; difference 2.4 mm, 95% CI 1.0–3.8; P = .002), by 3 months thickness reduction had converged between groups (8.2 vs. 8.4 mm; P = .91). Among 679 patients (456 multi-pedicle, 223 single-pedicle), favorable functional outcome (mRS 0–2) was more frequent with multi-pedicle embolization (53.5% vs. 43.0%; adjusted OR 1.81, 95% CI 1.26–2.60; P = .001), whereas recurrence, rescue surgery, and treatment failure did not differ. Conclusion: Future, multi-center randomized prospective trials are warranted to address confounding variables that limit this observational study. Follow-up beyond 3 months was limited, so durability is unknown.
- Open Access
- 20 August 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-14
Factors Associated with Short Hospital Stay After Combined Middle Meningeal Artery Embolization and Surgical Evacuation for Chronic Subdural Hematoma
Background: Middle meningeal artery embolization (MMAE) plus surgical evacuation is increasingly used for chronic subdural hematoma (cSDH), but predictors of length of stay (LOS) and outcomes associated with early discharge remain unclear. Methods: We performed a multicenter MESH Registry study (2019–2024) of patients undergoing MMAE and surgical evacuation for symptomatic cSDH. Short-stay discharge was defined as LOS ≤4 days. Predictors were identified using multivariable logistic regression. The 90-day composite adverse event was defined as cSDH recurrence requiring intervention, reintervention (repeat MMAE or surgical evacuation), or 30-day all-cause readmission. Safety was assessed using adjusted logistic regression, generalized estimating equations (GEE), inverse probability of treatment weighting (IPTW), and multiple imputation by chained equations (MICE). Results: Among 647 patients (mean age 72.6 years; 74.0% male), 156 (24.1%) had short-stay discharge. Median LOS was 8 days (IQR 5–15). Older age (aOR 0.76 per 10 years; 95% CI 0.62–0.93; P = 0.008), higher baseline modified Rankin Scale score (aOR 0.79 per point; 95% CI 0.67–0.94; P = 0.007), and greater midline shift (aOR 0.90 per mm; 95% CI 0.85–0.96; P = 0.001) were independently associated with lower odds of short-stay discharge. C‑statistic was 0.683. The 90-day composite event rate was 17.1% in short-stay versus 23.7% in long-stay patients. Short-stay discharge was not significantly associated with the composite outcome on adjusted analysis (aOR 0.56; 95% CI 0.30–1.07; P = 0.08), GEE (aOR 0.61; 95% CI 0.33–1.12; P = 0.11), or MICE (aOR 0.74; 95% CI 0.44–1.25; P = 0.26). IPTW showed a discordant association (OR 0.47; 95% CI 0.24–0.92; P = 0.03). Conclusions: Older age, worse baseline function, and midline shift were associated with longer hospitalization. Short-stay discharge was not associated with a statistically significant increase in adverse-event rates; however, the study was not powered to establish non-inferiority or safety equivalence, and clinically meaningful differences cannot be excluded.
- 20 August 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-14
Open AccessFactors Associated with Short Hospital Stay After Combined Middle Meningeal Artery Embolization and Surgical Evacuation for Chronic Subdural Hematoma
Background: Middle meningeal artery embolization (MMAE) plus surgical evacuation is increasingly used for chronic subdural hematoma (cSDH), but predictors of length of stay (LOS) and outcomes associated with early discharge remain unclear. Methods: We performed a multicenter MESH Registry study (2019–2024) of patients undergoing MMAE and surgical evacuation for symptomatic cSDH. Short-stay discharge was defined as LOS ≤4 days. Predictors were identified using multivariable logistic regression. The 90-day composite adverse event was defined as cSDH recurrence requiring intervention, reintervention (repeat MMAE or surgical evacuation), or 30-day all-cause readmission. Safety was assessed using adjusted logistic regression, generalized estimating equations (GEE), inverse probability of treatment weighting (IPTW), and multiple imputation by chained equations (MICE). Results: Among 647 patients (mean age 72.6 years; 74.0% male), 156 (24.1%) had short-stay discharge. Median LOS was 8 days (IQR 5–15). Older age (aOR 0.76 per 10 years; 95% CI 0.62–0.93; P = 0.008), higher baseline modified Rankin Scale score (aOR 0.79 per point; 95% CI 0.67–0.94; P = 0.007), and greater midline shift (aOR 0.90 per mm; 95% CI 0.85–0.96; P = 0.001) were independently associated with lower odds of short-stay discharge. C‑statistic was 0.683. The 90-day composite event rate was 17.1% in short-stay versus 23.7% in long-stay patients. Short-stay discharge was not significantly associated with the composite outcome on adjusted analysis (aOR 0.56; 95% CI 0.30–1.07; P = 0.08), GEE (aOR 0.61; 95% CI 0.33–1.12; P = 0.11), or MICE (aOR 0.74; 95% CI 0.44–1.25; P = 0.26). IPTW showed a discordant association (OR 0.47; 95% CI 0.24–0.92; P = 0.03). Conclusions: Older age, worse baseline function, and midline shift were associated with longer hospitalization. Short-stay discharge was not associated with a statistically significant increase in adverse-event rates; however, the study was not powered to establish non-inferiority or safety equivalence, and clinically meaningful differences cannot be excluded.
- 11 August 2026
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
Chiari I Malformation in Pregnancy: A Retrospective Review of Maternal Outcomes and Anesthetic Safety, and a Survey of Current Practices
We sought to evaluate outcomes of pregnant patients with Chiari malformation (CM). We evaluated the relationships between mode of anesthesia and delivery with neurologic outcome in these patients. We conducted a single-center, retrospective review of pregnant patients with CM between 2008 and 2024. Clinical and radiographic data were collected. Additionally, three neurosurgeons retrospectively determined eligibility for vaginal delivery with the Valsalva maneuver and neuraxial anesthesia with the available information. We identified 56 deliveries in 40 patients with Type I CM. Median tonsillar descent was 8 mm (interquartile range [IQR] 4.5–11.5). Seven deliveries (16.7%; six patients) featured patients with syrinxes (median diameter 4.5 mm, IQR 4.0–4.5 mm). During pregnancy, 11 patients (19.6%) had symptoms attributable to CM, most commonly headache (5 patients, 8.9%). Two (40%) patients with Chiari-related headaches experienced worsening symptoms during pregnancy. Twenty-two pregnancies resulted in vaginal deliveries (39.3%), and 34 in cesarean deliveries (60.7%). Eleven cesarean deliveries (32.3%; 19.6% of whole cohort) had primary indication of CM for operative delivery. Neuraxial anesthesia was used in 29 patients (52%), 17 of whom were for cesarean deliveries (50% of cesareans). During labor, there were no maternal mortalities or worsening CM-related symptoms. On blinded retrospective assessment, one neurosurgeon found 51/56 deliveries (91.1%) safe for vaginal delivery and all safe for neuraxial anesthesia; one neurosurgeon found all deliveries safe for vaginal delivery and neuraxial anesthesia; the last one found 54/56 deliveries (96.4%) safe for vaginal delivery and 55/56 (98.2%) safe for neuraxial anesthesia. Concerns arose from brainstem compression and foramen magnum crowding with symptomatic worsening during pregnancy. A diagnosis of Type I CM imparts higher rates of cesarean delivery (61%) and lower rates of neuraxial anesthesia to pregnant persons. Yet, our outcomes suggest that vaginal delivery with the Valsalva maneuver and neuraxial anesthesia appear to be safe in almost all pregnant patients with CM.
- 11 August 2026
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
Chiari I Malformation in Pregnancy: A Retrospective Review of Maternal Outcomes and Anesthetic Safety, and a Survey of Current Practices
We sought to evaluate outcomes of pregnant patients with Chiari malformation (CM). We evaluated the relationships between mode of anesthesia and delivery with neurologic outcome in these patients. We conducted a single-center, retrospective review of pregnant patients with CM between 2008 and 2024. Clinical and radiographic data were collected. Additionally, three neurosurgeons retrospectively determined eligibility for vaginal delivery with the Valsalva maneuver and neuraxial anesthesia with the available information. We identified 56 deliveries in 40 patients with Type I CM. Median tonsillar descent was 8 mm (interquartile range [IQR] 4.5–11.5). Seven deliveries (16.7%; six patients) featured patients with syrinxes (median diameter 4.5 mm, IQR 4.0–4.5 mm). During pregnancy, 11 patients (19.6%) had symptoms attributable to CM, most commonly headache (5 patients, 8.9%). Two (40%) patients with Chiari-related headaches experienced worsening symptoms during pregnancy. Twenty-two pregnancies resulted in vaginal deliveries (39.3%), and 34 in cesarean deliveries (60.7%). Eleven cesarean deliveries (32.3%; 19.6% of whole cohort) had primary indication of CM for operative delivery. Neuraxial anesthesia was used in 29 patients (52%), 17 of whom were for cesarean deliveries (50% of cesareans). During labor, there were no maternal mortalities or worsening CM-related symptoms. On blinded retrospective assessment, one neurosurgeon found 51/56 deliveries (91.1%) safe for vaginal delivery and all safe for neuraxial anesthesia; one neurosurgeon found all deliveries safe for vaginal delivery and neuraxial anesthesia; the last one found 54/56 deliveries (96.4%) safe for vaginal delivery and 55/56 (98.2%) safe for neuraxial anesthesia. Concerns arose from brainstem compression and foramen magnum crowding with symptomatic worsening during pregnancy. A diagnosis of Type I CM imparts higher rates of cesarean delivery (61%) and lower rates of neuraxial anesthesia to pregnant persons. Yet, our outcomes suggest that vaginal delivery with the Valsalva maneuver and neuraxial anesthesia appear to be safe in almost all pregnant patients with CM.
- Open Access
- 10 July 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (5) , 101584
Impact of middle meningeal artery embolization timing on chronic subdural hematoma resolution and functional outcomes
- 10 July 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (5) , 101584
Open AccessImpact of middle meningeal artery embolization timing on chronic subdural hematoma resolution and functional outcomes
- Open Access
- 1 December 2025
- Published by AME Publishing Company in Journal of Spine Surgery
- Vol. 11 (4) , 828-839
Brace yourself: routine postoperative bracing after adult spinal deformity surgery offers no clinical benefit and may increase harm
Background: Adult spinal deformity (ASD) can result in debilitating symptoms and often necessitates surgical intervention. Postoperative complications—including thromboembolic events, proximal junctional kyphosis (PJK), pseudoarthrosis, and rod fracture—are common and can severely impact outcomes. While spinal bracing is commonly employed postoperatively, its’ clinical value remains unproven. The aim of this study was to compare complication rates, pain levels, and outcomes between patients who received thoracolumbosacral orthosis (TLSO) bracing and those who did not following ASD surgery. Methods: We conducted a retrospective review of consecutive ASD surgeries at our tertiary care center between 2016 and 2023. ASD surgery was defined as multilevel fusion involving at least 5 vertebral levels, extending from the pelvis to L2 or above. Surgical approaches included open or minimally invasive methods via different interbodies such as transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), or lateral lumbar interbody fusion (LLIF). Nine surgeons participated in the cohort. Results: Of 265 patients, 193 (73%) received TLSO bracing postoperatively. Braced patients had a significantly increased risk of rhabdomyolysis [odds ratio (OR) =9.959; PConclusions: Routine bracing following ASD surgery does not reduce mechanical or surgical complications and may contribute to immobility-related morbidity and prolonged pain management. Forgoing postoperative bracing may improve patient outcomes and reduce healthcare costs. These findings support a reevaluation of routine bracing in ASD care.
- 1 December 2025
- Published by AME Publishing Company in Journal of Spine Surgery
- Vol. 11 (4) , 828-839
Open AccessBrace yourself: routine postoperative bracing after adult spinal deformity surgery offers no clinical benefit and may increase harm
Background: Adult spinal deformity (ASD) can result in debilitating symptoms and often necessitates surgical intervention. Postoperative complications—including thromboembolic events, proximal junctional kyphosis (PJK), pseudoarthrosis, and rod fracture—are common and can severely impact outcomes. While spinal bracing is commonly employed postoperatively, its’ clinical value remains unproven. The aim of this study was to compare complication rates, pain levels, and outcomes between patients who received thoracolumbosacral orthosis (TLSO) bracing and those who did not following ASD surgery. Methods: We conducted a retrospective review of consecutive ASD surgeries at our tertiary care center between 2016 and 2023. ASD surgery was defined as multilevel fusion involving at least 5 vertebral levels, extending from the pelvis to L2 or above. Surgical approaches included open or minimally invasive methods via different interbodies such as transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), or lateral lumbar interbody fusion (LLIF). Nine surgeons participated in the cohort. Results: Of 265 patients, 193 (73%) received TLSO bracing postoperatively. Braced patients had a significantly increased risk of rhabdomyolysis [odds ratio (OR) =9.959; PConclusions: Routine bracing following ASD surgery does not reduce mechanical or surgical complications and may contribute to immobility-related morbidity and prolonged pain management. Forgoing postoperative bracing may improve patient outcomes and reduce healthcare costs. These findings support a reevaluation of routine bracing in ASD care.
- Open Access
- 14 June 2025
- Published by Elsevier in World Neurosurgery
- Vol. 200, 124186
Enhanced Visualization, Reduced Burden: Endoscopic versus Tubular Spine Surgery for Lumbar Stenosis
- 14 June 2025
- Published by Elsevier in World Neurosurgery
- Vol. 200, 124186
Open AccessEnhanced Visualization, Reduced Burden: Endoscopic versus Tubular Spine Surgery for Lumbar Stenosis
Neuropsychological outcomes of hippocampus‐sparing anterior temporal lobectomy versus stereotactic laser amygdalohippocampectomy in language‐dominant temporal lobe epilepsy
Objective: Postoperative neuropsychological deficits pose a significant challenge for temporal lobe epilepsy (TLE) surgery, particularly in the language‐dominant hemisphere. Two surgical approaches have been suggested to mitigate such adverse outcomes: stereotactic laser amygdalohippocampectomy (SLAH) and hippocampus‐sparing anterior temporal lobectomy (HSATL). This retrospective cohort study compares the seizure control and neuropsychological outcomes of HSATL and SLAH in language‐dominant TLE. Methods: A retrospective cohort study compared 27 patients (nine male, mean age = 35.8 years) with drug‐resistant TLE and normal imaging localized to the language‐dominant left temporal lobe, undergoing either HSATL ( n = 22) or SLAH ( n = 5) between 2014 and 2021. Comprehensive pre‐ and ≥1‐year postoperative neuropsychological testing and imaging were performed, with seizure outcomes tracked for at least 1 year postoperatively. However, to assess the impact of mesial temporal sclerosis (MTS) on SLAH outcomes, we included seven additional patients with MTS who underwent SLAH in a secondary analysis. Results: HSATL led to significant declines in logical memory ( p = .04) despite sparing the hippocampus, which were not seen following SLAH in patients regardless of MTS status. SLAH trended toward improved semantic fluency, immediate verbal memory, and executive function despite hippocampal ablation. Including both MTS(+) and MTS(−) patients, there was a significant decline in letter fluency following SLAH (.04), with subgroup analyses demonstrating significantly greater declines in MTS(+) patients undergoing SLAH (.02). Additionally, 100% of patients undergoing SLAH achieved seizure freedom versus 72.7% following HSATL ( p = .046, including MTS[+] patients) at last follow‐up. Significance: In language‐dominant TLE, SLAH demonstrated comparable seizure outcomes and superior verbal memory retention compared to HSATL, albeit with greater letter fluency impairment. Preliminary findings challenge prioritizing hippocampal preservation for verbal memory function, suggesting potential cognitive advantages with SLAH specifically targeting mesial structures while maximally preserving cortical structures and white matter tracts critical for language networks. However, this intervention may negatively impact letter fluency, suggesting careful preoperative screening and discussion.
Neuropsychological outcomes of hippocampus‐sparing anterior temporal lobectomy versus stereotactic laser amygdalohippocampectomy in language‐dominant temporal lobe epilepsy
Objective: Postoperative neuropsychological deficits pose a significant challenge for temporal lobe epilepsy (TLE) surgery, particularly in the language‐dominant hemisphere. Two surgical approaches have been suggested to mitigate such adverse outcomes: stereotactic laser amygdalohippocampectomy (SLAH) and hippocampus‐sparing anterior temporal lobectomy (HSATL). This retrospective cohort study compares the seizure control and neuropsychological outcomes of HSATL and SLAH in language‐dominant TLE. Methods: A retrospective cohort study compared 27 patients (nine male, mean age = 35.8 years) with drug‐resistant TLE and normal imaging localized to the language‐dominant left temporal lobe, undergoing either HSATL ( n = 22) or SLAH ( n = 5) between 2014 and 2021. Comprehensive pre‐ and ≥1‐year postoperative neuropsychological testing and imaging were performed, with seizure outcomes tracked for at least 1 year postoperatively. However, to assess the impact of mesial temporal sclerosis (MTS) on SLAH outcomes, we included seven additional patients with MTS who underwent SLAH in a secondary analysis. Results: HSATL led to significant declines in logical memory ( p = .04) despite sparing the hippocampus, which were not seen following SLAH in patients regardless of MTS status. SLAH trended toward improved semantic fluency, immediate verbal memory, and executive function despite hippocampal ablation. Including both MTS(+) and MTS(−) patients, there was a significant decline in letter fluency following SLAH (.04), with subgroup analyses demonstrating significantly greater declines in MTS(+) patients undergoing SLAH (.02). Additionally, 100% of patients undergoing SLAH achieved seizure freedom versus 72.7% following HSATL ( p = .046, including MTS[+] patients) at last follow‐up. Significance: In language‐dominant TLE, SLAH demonstrated comparable seizure outcomes and superior verbal memory retention compared to HSATL, albeit with greater letter fluency impairment. Preliminary findings challenge prioritizing hippocampal preservation for verbal memory function, suggesting potential cognitive advantages with SLAH specifically targeting mesial structures while maximally preserving cortical structures and white matter tracts critical for language networks. However, this intervention may negatively impact letter fluency, suggesting careful preoperative screening and discussion.